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The bile salt glycocholate induces 
global changes in gene and protein 
expression and activates virulence 
in enterotoxigenic Escherichia coli
Enrique Joffre  1, Matilda Nicklasson2, Sandra Álvarez-Carretero1, Xue Xiao3, Lei Sun1, 
Intawat Nookaew4, Baoli Zhu3,5,6 & Åsa Sjöling  1
Pathogenic bacteria use specific host factors to modulate virulence and stress responses during 
infection. We found previously that the host factor bile and the bile component glyco-conjugated 
cholate (NaGCH, sodium glycocholate) upregulate the colonization factor CS5 in enterotoxigenic 
Escherichia coli (ETEC). To further understand the global regulatory effects of bile and NaGCH, we 
performed Illumina RNA-Seq and found that crude bile and NaGCH altered the expression of 61 genes 
in CS5 + CS6 ETEC isolates. The most striking finding was high induction of the CS5 operon (csfA-F), its 
putative transcription factor csvR, and the putative ETEC virulence factor cexE. iTRAQ-coupled LC-MS/
MS proteomic analyses verified induction of the plasmid-borne virulence proteins CS5 and CexE and 
also showed that NaGCH affected the expression of bacterial membrane proteins. Furthermore, NaGCH 
induced bacteria to aggregate, increased their adherence to epithelial cells, and reduced their motility. 
Our results indicate that CS5 + CS6 ETEC use NaGCH present in the small intestine as a signal to initiate 
colonization of the epithelium.
Enterotoxigenic Escherichia coli (ETEC) is one of the most common bacterial causes of acute watery diarrhea in 
the developing world, both among children under five years old and in indigenous adults or travelers to endemic 
regions1. ETEC also causes food-borne outbreaks of gastroenteritis in the US and Europe and is often spread 
by contaminated food and water2,3. ETEC colonizes the small intestine, where diarrhea is caused by at least one 
of two enterotoxins, a heat-stable toxin (ST, including the human STh and human/porcine STp subtypes) or a 
heat-labile toxin (LT)4. Adhesion to the epithelium of the small intestine is mediated by colonization factors 
(CFs), a heterogeneous group of fimbrial, fibrillar, and afimbrial structures on the bacterial surface. Thus, far up to 
27 CFs have been described and verified5–11; these may be expressed alone or in different combinations depending 
on the ETEC strain4. Both the enterotoxins and CFs are encoded on plasmids12.
Upon entering the host, ETEC bacteria must pass through the acidic environment of the stomach; overcome 
the bactericidal effects of bile in the duodenum, jejunum, and ileum; and traverse the mucous layer of the small 
intestine before colonizing the epithelial surface and establishing an infection. Several enteropathogenic bacteria 
are known to respond to host factors and to alter the expression of virulence factors in response to conditions in 
the gastrointestinal tract (e.g., pH, bile, bicarbonate, mucus, alkalinity, and high osmolarity)13–21. Thus, they are 
able to adjust their degree of virulence to the most favorable niche of infection.
An important host factor is bile, which is produced by the liver, stored in the gallbladder, and secreted into 
the duodenum. Bile is composed primarily of un-conjugated and glyco- or tauro-conjugated bile salts, as well as 
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cholesterol, phospholipids, and biliverdin13,14. The concentration of bile salt in the duodenum varies between 0.2% 
and 2%15. Bile and some of its individual components, such as the major primary bile salt cholate and the sec-
ondary bile salt deoxycholate, as well as the conjugated primary salts taurocholate and glycocholate16, are known 
inducers of virulence in bacterial enteropathogens such as ETEC, V. cholerae, enteropathogenic E. coli (EPEC), 
Campylobacter jejuni, and Shigella spp17–22. Because it is a detergent, bile is also involved in the host antimicrobial 
defense, making it one of the most intriguing host signals affecting virulence. To colonize the human intestine, 
enteric bacteria such as E. coli and V. cholerae overcome bile toxicity by regulating outer membrane porins and 
efflux systems, including ompU and acrAB-tolC, to induce bile resistance23,24.
Five ETEC CFs are only expressed on the bacterial surface when bile is present25. One such bile-induced 
colonization factor is coli surface antigen 5 (CS5), one of the most common CFs detected worldwide26. CS5 is a 
fibrillar antigen, and its operon encodes a major subunit (csfA), a minor subunit (csfD), an outer membrane usher 
(csfC), two chaperones (csfB and csfF), and a protein involved in regulating pilus length (csfE)27. ETEC strains 
expressing CS5 also co-express the operon encoding coli surface antigen 6 (CS6)6,26. We showed recently that 
two individual bile salts, sodium glycocholate (NaGCH) and sodium deoxycholate (NaDC), are each sufficient to 
induce the expression of CS5 in vitro17. NaGCH is the sodium salt of the glyco-conjugated primary bile cholic acid 
and is one of the main components of bile28. In contrast to NaDC, NaGCH had previously not been reported to 
induce virulence among enteropathogenic bacteria18,20,29. The goal of the present study was to further explore the 
contribution of bile, and NaGCH in particular, to global gene and protein expression in ETEC strains expressing 
CS5 and CS6. To this end, we employed a whole- transcriptome and -proteome approach using RNA sequencing 
and iTRAQ-coupled LC-MS/MS technology.
Results
Bile and the major bile component NaGCH modulate the ETEC transcriptome during mid-loga-
rithmic growth. Two ETEC clinical isolates, E1777 and E2265, each expressing the virulence factors LT, STh, 
CS5, and CS6 were analyzed by RNA-Seq for their transcriptional response to bile (0.15%) and the bile compo-
nent NaGCH (0.2%). Genes up- or down-regulated at least three-fold relative to LB medium were analyzed fur-
ther; isolate-specific differences in gene expression were excluded to only consider changes in both isolates. With 
these criteria, we identified 61 genes that were differentially expressed in LB versus bile or in LB versus NaGCH 
(Fig. 1a, Supplementary Table S1). Among these 61 genes, we found 3 expression patterns: 35 genes were induced 
by bile and/or NaGCH; 17 genes were repressed by bile and/or NaGCH; and 9 genes were not affected or were 
downregulated by bile, but upregulated by NaGCH (Fig. 1a).
Bile and NaGCH affect the expression of genes involved in fatty acid degradation and thre-
onine/serine metabolism. To further explore the effects of bile and NaGCH, we searched the KEGG 
DATABASE for the differentially expressed genes identified with RNA-Seq. Bile, but not NaGCH, upreg-
ulated genes for fatty acid degradation, including fadE and fadI (for fatty acid β-oxidation), fadM (for oleate 
β-oxidation), and fadH (intermediate reductase) (Fig. 1a and b, Supplementary Table S1). Conversely, NaGCH 
affected genes involved in the transport and metabolism of threonine and serine. NaGCH, but not bile, upreg-
ulated tdcA (transcriptional activator of the tdcABC operon) and tdcC (the threonine-serine permease); these 
effects were especially prominent in E2265, with more than a 25-fold change in gene expression (Fig. 1b).
Several of the changes in gene expression were more pronounced in the presence of NaGCH than bile, only 
reaching significance with NaGCH. Because NaGCH is a fraction of the crude bile mix, these genes might 
respond specifically to NaGCH in a dose-dependent manner. For example, bsmA, yodD (both biofilm-related), 
and adrB/yoaD (for cellulose synthesis) were significantly upregulated by NaGCH, but less so by bile (Fig. 1). 
Several genes involved in nitrogen metabolism, narU, norR, and glnG, were upregulated by both NaGCH and 
bile, but narK was only upregulated by NaGCH (Fig. 1, Supplementary Table S2). These results indicate that the 
complex mix of components in bile might mask the specific action of NaGCH. However, it is clear that NaGCH 
induces significant changes in gene expression in ETEC.
Bile and NaGCH induce ETEC-specific virulence factors but downregulate flagella genes and 
PhoB. The genes most significantly upregulated by bile and NaGCH were virulence genes (Fig. 1b). Consistent 
with our previous results17, csfA (CS5 major subunit), csfD (CS5 minor subunit), and csfC (outer membrane 
usher), all members of the CS5 operon, were highly induced by both bile and NaGCH. Likewise, bile and NaGCH 
upregulated csvR, a member of the AraC/XylS family of transcriptional regulators, and likely the positive regu-
lator of CS56. However, the most abundant transcript found in E1777 and E2265 strains in the presence of either 
bile or NaGCH corresponded to a variant of the plasmid-encoded gene cexE (cfaD-dependent expression, extra-
cytoplasmic protein) (Fig. 1b). CexE was described recently as a putative ETEC virulence factor30.
Two genes associated directly with ETEC pathogenesis, gspD and ycfS, were significantly downregulated in 
bile and tended toward downregulation in NaGCH; gspD is part of the type-2 secretion system involved in LT 
secretion, and ycfS is involved in flagella biogenesis and motility (Fig. 1a and b). Finally, the transcription factor 
phoB, part of the two-component system that positively regulates the phosphate regulon, and the gene fliC that 
encodes the flagellin, were strongly downregulated by both bile and NaGCH (Fig. 1b, Supplementary Table S1).
Effects of NaGCH on the quantitative proteomic profile of CS5 + CS6 ETEC during stationary 
phase. To determine if the changes induced by NaGCH on gene expression correlated with changes in pro-
tein levels, we performed a quantitative proteomic analysis on strains E1777 and E2265 grown to stationary 
phase. With iTRAQ labeling and liquid chromatography combined with tandem mass spectroscopy (MM/MS), 
we identified 1,480 differentially produced proteins in E1777 and 1,231 differentially produced proteins in E2265 
(false-discovery rate < 1%). A fold change in protein abundance of ≤0.8 (downregulated) or ≥1.2 (upregulated) 
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(and with at least 2 unique peptides) was considered significant. Considering these criteria, NaGCH increased 
the abundance of 88 proteins in E1777 and decreased the abundance of 78 proteins (Supplementary Table S2). 
In E2265, NaGCH increased the abundance of 107 proteins and decreased the abundance 86. Overall, NaGCH 
increased the levels of 26 proteins common to both isolates and decreased 46 (Fig. 2, Supplementary Table S2).
Proteomic data confirm upregulation of CS5 and CexE. Consistent with the transcriptomic analysis, 
peptides of the CS5 fimbrial subunit CsfD and the outer membrane protein CexE, both virulence proteins, were 
most abundant after exposure to NaGCH (Fig. 2, Supplementary Table S2). However, there was no significant 
change in the abundance of CsvR, the proposed transcriptional activator of CS5, indicating that it was likely 
transiently upregulated during exponential phase. To confirm this, we measured csvR expression with qRT-PCR 
during exponential and stationary growth; we found that csvR was expressed during exponential growth, but 
expression then declined (Figs 3 and 4). We also found that NaGCH decreased the abundance of CS6, which is 
co-expressed in the ETEC strains in this study (Fig. 2, Supplementary Table S2). This trend was not observed in 
our transcriptomic analysis and could not be confirmed by qRT-PCR.
NaGCH upregulates membrane and cell wall proteins during stationary phase. Our proteomic 
analysis showed that NaGCH significantly increased the abundance of several proteins involved in biofilm forma-
tion, cellulose production, and the cell envelope, including Blc and YfiO (lipoproteins anchored to the periplasmic 
face), outer membrane proteins BepA and YfgM, and MipA, DacA, and DacC (involved in peptidoglycan bio-
synthesis and structure). In addition, NaGCH upregulated the amino acid uptake/transport proteins GlnQ, GltL, 
PheA, and PutP (Fig. 2, Supplementary Table S2).
NaGCH also induced the production of the acetate operon repressor IclR and the global regulator Lrp (Fig. 2, 
Supplementary Table S2). Finally, we observed increased levels of AtpC (responsible for proton transport), 
Figure 1. Modulation of ETEC transcriptome in the presence of bile or NaGCH. (a) Heat map and hierarchical 
clustering of 61 genes differentially expressed (>3-fold change) in the presence of bile or NaGCH in the 
CS5 + CS6 ETEC strains E1777 and E2265. Color scale represents relative expression levels: green indicates low 
level (downregulated genes), red indicates high level (upregulated genes), and black indicates no change. (b) The 
10 genes most significantly upregulated (red) or downregulated (green) by bile or NaGCH, including KEGG 
pathways of the corresponding genes. Values are the average fold change for E1777 and E2265.
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FadA (fatty acid oxidation), NlpD (cell division), TrxA (redox homeostasis), and Ung (DNA repair) (Fig. 2, 
Supplementary Table S2).
NaGCH represses proteins involved in stress responses, central metabolism, and transla-
tion. A number of proteins were significantly downregulated by NaGCH in both ETEC strains (Fig. 2 and 
Supplementary Table S2). Many these proteins are involved in different stress responses, including OsmY, YgaU, 
YciE, YciF, and YhbO (osmotic stress); AcnA, KatE, YdbK, YhbO, and PoxB (oxidative stress); YgiW and SodC 
(hydrogen peroxide stress); HdeB and GadC (pH stress); and AppA and Dps (starvation). We also observed 
decreases in stationary-phase 50 S (L32 and L33) and 30 S (S19, essential; S20, non-essential) ribosomal proteins, 
as well as the ribosome-associated proteins RMF and SRA. NaGCH treatment also decreased the production of 
the multidrug transporters MdtE and MdtF, which were associated to multidrug resistance, enterobactin secre-
tion, and iron homeostasis31. Likewise, NaGCH decreased the abundance of the tryptophanase TnaA, which 
converts tryptophan into indole, ammonia, and pyruvate, allowing E. coli to use tryptophan as a sole source of 
carbon and nitrogen. Indole is a signaling molecule that represses biofilm formation and motility and regulates 
virulence in EHEC and EAEC32,33.
The p1 ETEC plasmid contains several bile-/NaGCH-inducible virulence genes. We suspected 
that csvR, csfD, and cexE, the most highly induced virulence-associated genes, were plasmid borne. Therefore, 
we used PacBio sequencing to analyze plasmid DNA from strain E2265; we confirmed that these and other 
virulence-associated genes were encoded on a large 142-kb plasmid. As is illustrated in Fig. 5 csvR was prox-
imally upstream of an araC homolog. Downstream of this gene were eatA (ETEC autotransporter A) and the 
CS5 (csfABCEFD) and CS6 operons (cssABCD), oriented head-to-head. Next to these CF operons, we identified 
estA3 (heat stable toxin, STh), the aatPABCD operon (Aat translocator system for dispersin homolog), and cexE 
(Fig. 5). Comparing sequences, we found that E2265 cexE was only 72% similar to the H10407 ETEC cexE (acc. 
No. EF205439.1); however, it was 100% identical to a previously annotated sequence in the draft whole-genome 
sequence of another CS5 + CS6 ST ETEC strain34 and to a non-annotated sequence on a CS6-encoding plasmid35. 
We deposited the sequence of the E2265 plasmid at GenBank (accession no. CP023347)36.
Bile and NaGCH activate virulence in CS5 + CS6 ETEC strains from a globally distributed ETEC 
linage. To validate our transcriptomic and proteomic data and determine if adjacent plasmid-borne viru-
lence genes were also induced by bile/NaGCH, we performed qRT-PCR with E1777 and E2265 after 3 hours or 
overnight growth (ON) (Fig. 3). As expected, NaGCH significantly increased the expression of csvR, csfD, and 
cexE after 3 hours of growth. In addition, aatP expression was upregulated by bile and NaGCH. After overnight 
growth, the gene expressions of all four virulence genes were drastically reduced compared to 3 hours of growth 
in LB. When bacteria were exposed to bile or NaGCH, virulence gene expression showed a tendency of being 
higher than in the ON LB control but the expression levels significantly lower than after 3 hours of growth (Fig. 3). 
Hence, bile and NaGCH induction of virulence is transient and occur in exponential growth phase.
Figure 2. Quantitative proteomic analysis of ETEC isolates (E2265 and E1777) treated with 0.2% NaGCH. 
Graph shows fold change in protein abundance after NaGCH exposure; fold change <0.8 indicates a significant 
decrease, fold change >1.2 indicates a significant increase. Proteins were organized with GraphPad Prism 7.00 
for Mac OS X based on their respective pathways.
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Next, we sought to address whether bile and NaGCH activate pathogen-specific genes in other CS5 + CS6 
ETEC strains from the ETEC L5 lineage37. For these experiments, we performed qRT-PCR on 10 additional 
ETEC clinical isolates after 3 hours or ON growth. As with the E1777 and E2265 isolates, bile and NaGCH signif-
icantly upregulated virulence gene expression in these 10 CS5 + CS6 ETEC strains (Fig. 4). The most significantly 
upregulated gene was the CS5 transcription factor csvR (bile, 9.7- to 312.1-fold; NaGCH, 12.2- to 452.4-fold). 
The genes csfD (CS5 minor subunit) and cexE were also upregulated significantly by bile (csfD, 23.8- to 83.4-fold; 
Figure 3. Validation of RNA-Seq and proteomic data by quantitative real-time RT-PCR. mRNA from ETEC 
isolates E1777 and E2265 was extracted after 3 hours or 24 hours (ON) of growth in LB, LB + 0.15% bile, or 
LB + 0.2% NaGCH. Relative mRNA expression values are the mean plus standard deviation (error bars) of at 
least three independent experiments. Asterisks indicate significant difference by one-way ANOVA (*P < 0.05; 
**P < 0.01; ***P < 0.001; ****P < 0.0001) using GraphPad Prism 7.00 for Mac OS X.
Figure 4. Expression of virulence-associated genes in globally distributed CS5 + CS6 ETEC strains. mRNA 
from 10 CS5 + CS6 ETEC isolates was extracted after 3 hours or 24 hours (ON) of growth in LB, LB + 0.15% 
bile, or LB + 0.2% NaGCH. Quantitative real-time RT-PCR was used to analyze differential gene expression. 
Relative mRNA expression values are the mean plus standard deviation (error bars) of three independent 
experiments. Asterisks indicate significant difference by one-way ANOVA (*P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001) using GraphPad Prism 7.00 for Mac OS X.
Figure 5. Linear representation of plasmid p1 from ETEC E2265. PacBio sequencing and analysis of the largest 
plasmid in E2265 (142359 bp, GenBank Accession number CP02334) with virulence-associated genes that 
were induced by bile and NaGCH (red arrows). Magenta arrows, ORFs; gray arrows, insertion sequences; blue 
arrows, virulence genes not induced by bile and NaGCH; and black arrows, Tra (transfer) genes.
www.nature.com/scientificreports/
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cexE, 6.5- to 78.8-fold) and NaGCH (csfD, 100.6- to 293.4-fold; cexE, 8.5- to 214.4-fold), while aatP was induced 
to a lesser extent (bile, 4.81- to 22.7-fold; NaGCH, 8.82- to 50.7-fold). Although the ETEC strains were variably 
induced, our data indicate that NaGCH had a more profound effect on gene expression than bile. Similar to 
E2265 and E1777, after overnight growth the expression of virulence genes in LB significantly dropped, and 
bile or NaGCH supplementation increased their expression but no significance was found (Fig. 4). We conclude 
that physiological concentrations of bile and NaGCH contribute significantly to upregulating virulence genes in 
CS5 + CS6 ETEC during exponential growth phase.
The bile salt NaGCH induces CS5-dependent bacterial co-aggregation. We observed that our bac-
terial cultures aggregated into clumps during growth with bile or NaGCH. This aggregation was most evident in 
the presence of NaGCH, where NaGCH-treated cells sedimented more rapidly than bile-treated ones (Fig. 6a 
and b). To determine if the CFs CS5 and CS6 played a role during bacterial co-aggregation, we generated E2265 
ΔcsfABCEFD (ΔCS5) and E2265 ΔcssABCD (ΔCS6) mutants and assessed them for aggregation in liquid cul-
ture in the presence of bile or NaGCH. We found that the ΔCS5 mutant did not aggregate or settle when exposed 
to bile or NaGCH, while the ΔCS6 did (Fig. 6a and b). Collectively, these data suggest that CS5 mediates bile- and 
NaGCH- dependent cell–cell aggregation.
NaGCH induces bacterial adherence to epithelial cells. Because NaGCH induced CS5 expression, 
we speculated that it might also affect the attachment of ETEC to intestinal epithelial cells. To evaluate bacte-
rial attachment, we co-cultured Caco-2 cells with five CS5 + CS6 ETEC clinical isolates in the presence of 0.2% 
NaGCH. Indeed, we found that NaGCH significantly enhanced the ability of ETEC cells to attach to Caco-2 cells 
compared to untreated ETEC (Fig. 7a).
To determine if epithelial cell attachment was, like aggregation, dependent on CS5, we co-cultured Caco-2 
cells with E2265 ΔCS5 or E2265 ΔCS6. We found that, compared to wild type E2265, NaGCH decreased the abil-
ity of the ΔCS5 strain to adhere to the Caco-2 cells (p < 0.0001) (Fig. 7b), while NaGCH did not affect attachment 
in the ΔCS6 mutant. These data suggest that the NaGCH-induced attachment of ETEC to intestinal epithelial 
cells depends on CS5.
NaGCH does not enhance classical biofilm formation. Bile and its components are known to induce 
biofilm formation38–40. To determine if the aggregation phenotype induced by bile salts was associated with 
the formation of a traditional biofilm, where single cells attach to a surface, divide and develop into mature, 
three-dimensional structures, we assayed biofilm formation for wild type E2265, ΔCS5, and ΔCS6 cells in the 
presence of bile or NaGCH (Supplementary Figure S1a). Since glucose in the medium might promote biofilm 
formation40 we performed additional experiments with and without addition of 0.4% glucose. Evaluation of 
surface-attached bacteria by Crystal violet staining that did not show any significant biofilm induction in pres-
ence of bile salts (Supplementary Figure S1). Similarly, analysis of the red-dry-rough (rdar) phenotype and quan-
tification of extracellular polymeric substances (EPS) using congo red (CR) and concanavalin A (ConA) staining, 
respectively did not show any enhanced biofilm formation (Supplementary Figure S1b and c). Addition of glucose 
did not influence biofilm formation. Additional gene expression analysis of four biofilm-related genes showed 
significant NaGCH-induced upregulation of the genes rcdA (regulator of biofilm master regulator CsgD) and 
bsmA (lipoprotein) while there were no significant changes in the gene expression of csgA (major curli subunit) 
and bscB (cellulose synthesis) (Supplementary Figure S1d). This suggested that NaGCH-induced aggregation 
occurred independently of the classical biofilm regulators.
Figure 6. Bile and NaGCH induce bacterial co-aggregation mediated by the CF CS5. (a) Cell–cell aggregation 
and (b) settling patterns of ETEC E2265 and its isogenic mutants (E2265 ΔCS5 and E2265 ΔCS6) after growth 
in the presence of 0.15% bile or 0.2% NaGCH. Liquid suspensions of bacterial cells were left standing for 
24 hours, and the OD600 of planktonic bacteria was measured at the times indicated and the mean and standard 
deviation (error bars) were plotted. Comparisons between control (E2265 in LB) with E2265 + 0.15% bile, 
E2265 + 0.2% NaGCH, E2265 ΔCS6 + 0.15% bile, and E2265 ΔCS6 + 0.2% showed significant differences 
(P < 0.001).
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Motility is downregulated in response to bile and NaGCH. Bile and NaGCH down-regulated the 
expression of the flagellin gene fliC in E2265 and E1777. To determine if this decrease in fliC expression affected 
motility, we performed motility assays by culturing the cells on soft agar. Crude bile affected the agar such that 
we could not perform the assay. However, NaGCH clearly reduced bacterial motility (Supplementary Figure S2).
Our results indicate that the bile salt NaGCH upregulates the expression of virulence factors in ETEC, 
induces bacterial aggregation, and enhances adherence to host epithelial cells (evidently a conserved feature 
among CS5 CS6 ETEC clinical isolates). Further, we demonstrated that the CF CS5 plays a major role in these 
NaGCH-dependent phenotypes (Fig. 8).
Figure 7. Role of NaGCH and CFs in epithelial cell adherence. Adherence assays were performed for 3 hours 
in DMEM with 10% of FBS (“medium”) with or without 0.2% NaGCH. Percent bacteria adhered to Caco-2 
cells for (a) 5 CS5 + CS6 ETEC strains (E88, E1111, E1724, E1777, and E1779) and (b) E2265 and its isogenic 
mutants (E2265 ΔCS5 and E2265 ΔCS6). Assays were performed in triplicate, and graphs show the mean and 
standard deviation (error bars). The percentage of adhered bacteria was calculated as described in Materials 
and Methods. Asterisks indicate significant difference by one-way ANOVA (*P < 0.05; ****P < 0.0001) using 
GraphPad Prism 7.00 for Mac OS X.
Figure 8. Schematic overview of NaGCH signaling during ETEC infection. (a) In the proximal part of the small 
intestine, ETEC meets a high concentration of NaGCH. This downregulates bacterial motility but activates 
virulence, inducing bacteria–bacteria adherence and favoring bacteria–host interactions and attachment. (b) 
We speculate that when bacteria progress through the gut and NaGCH is reabsorbed and its concentration 
decreases, activating bacterial motility to disperse the cells occurs.
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Discussion
To successfully colonize the gut, bacterial pathogens depend on their ability to sense distinct host-derived mole-
cules in the intestinal tract. Bile is abundant in the gut and is encountered by enteric pathogens during the early 
stages of infection. Besides its role in fat absorption and its antimicrobial activity, bile is well-tolerated by many 
microbes and can induce virulence factors in enteric pathogens18,41–44. Bile is a complex mix of salts, cholesterol, 
phospholipids, and biliverdin, but up to 40% of the dry mass of the bile used in our experiments (Oxoid) was 
NaGCH.
We previously reported that bile induces expression of the colonization factor CS5 in ETEC,17,25 and we con-
firmed that NaGCH was the active bile component that induced CS5 expression in a dose-dependent manner and 
that CS5 was expressed on the bacterial surface during acute infection17. In the present study, we used more pow-
erful tools (RNA-Seq and iTRAQ-coupled LC-MS/MS) to demonstrate that bile and NaGCH modulate the global 
transcriptome and proteome of ETEC. Interestingly, NaGCH strongly induced the expression and translation of 
several plasmid-encoded genes located close to each other on a large virulence plasmid. We also found that CS5 
mediates bacterial–bacterial and bacterial–host cell interactions in response to NaGCH.
Bile secreted into the intestinal lumen acts a barrier to microbes, preventing them from colonizing the intes-
tines. Bile salts are highly effective detergents and antimicrobial agents; they solubilize lipids during digestion and 
exert a major selective pressure that modulates the gut microbiome45. Commensal and pathogenic enteric bac-
teria have evolved mechanisms to protect them from the antimicrobial effects of high concentrations of bile salts 
in the proximal small intestine23. Salmonella enterica serovar Typhimurium40,46, V. cholerae47, and enterohemor-
rhagic E. coli (EHEC)48 efficiently pump bile salts and other toxic compounds out of the cell via efflux transporters 
e.g AcrAB-TolC,. In this study, where we used 0.15% bile and 0.2% NaGCH, the genes and corresponding proteins 
encoding this efflux system showed a tendency of induction but were not significantly up-regulated using our 
criteria, nevertheless our results were consistent with another study that demonstrated a two-fold upregulation 
in response to bile49. Further, we previously described the upregulation of tolC transcription in ETEC expressing 
CS6 but not in ETEC expressing CS5 + CS650. This is consistent with our current results and suggests that tolC 
induction might differ between ETEC lineages.
We did not observe growth inhibition in the presence of the concentrations used (data not shown). Other 
studies have also found that physiological concentrations in the small intestine do not affect growth40. The pro-
teome data revealed that exposure to bile and NaGCH still had effect on expression of several proteins involved 
in cell wall composition and membrane stability after 24 hours of exposure. This might be part of the ETEC bile 
stress adaptation and shows that even physiological concentrations of bile and NaGCH induce big changes in the 
proteome of ETEC.
Many bacterial pathogens are capable to form biofilms in response to bile salts and several gram-negative 
pathogens i.e. V. cholerae51, Shigella flexneri40, and Salmonella spp38,52,53 respond with enhanced biofilm for-
mation in presence of bile. In CS5 + CS6 ETEC, the RNA-seq data showed that bsmA and yodD were the only 
biofilm-associated genes transcriptionally induced by NaGCH. In addition, reduced protein abundance of the 
biofilm regulator McbR, involved in E. coli biofilm development54 and increased expression of the yoaD gene 
involved in the degradation of cyclic di-GMP, a signal molecule that triggers cellulose biosynthesis found in 
our analysis correlates with the lack of significant induction of the phenotypic formation of a traditional biofilm 
in response to bile and NaGCH. This model involves the attachment of single planktonic bacteria to a surface 
and further development to a mature biofilm55. Nevertheless, we demonstrated that NaGCH induced formation 
of multicellular aggregates and increased bacterial adherence to epithelial cells and describe that this pheno-
type occurs in ETEC. Indeed, aggregates has been proposed to be an alternative model of biofilm formation in 
Pseudomonas aeruginosa56, where instead of single planktonic cell, multicellular clumps land on surfaces and 
initiate the biofilm formation process during its early development. In a study of S. flexneri40, the authors reported 
that bile salts induced bacterial aggregation, while both glucose and bile were needed for EPS and biofilm forma-
tion40. Contrary to these results we found that addition of glucose did not promote biofilm formation or EPS in 
CS5 CS6 expressing ETEC. In light of several recent reports of aggregation phenotypes in bacteria further studies 
are clearly needed to clarify the impact of aggregation during adherence to the host cells and biofilm formation 
as well as pathogen specific differences in responses to host cues. Similar to other pathogenic E. coli where aggre-
gation is mediated by adhesins such as adherence fimbriae AAF/I and AFF/II in EAEC, or bundle-forming pili in 
EPEC, we could show that the colonization factor CS5 not only plays an essential role during bacterial adherence 
to epithelial cells, but also is responsible of the aggregative phenotype of ETEC during bile exposure. Hence there 
seems to be a dual function of both adherence and aggregation linked to fimbriae expressed by pathogenic enteric 
bacteria, which should be further explored in relation to virulence.
Biofilm and/or adhesion to epithelium is often linked to increased motility. However, we observed reduced 
motility in soft agar and downregulation of the fliC gene in response to NaGCH. These results are corroborated 
by studies of EHEC, EPEC and Salmonella57–59, while Vibrio choleare and Campylobacter respond to bile with 
increased motility58. The results indicate that enteric pathogens respond to bile using different defense mecha-
nisms. E.g V. cholerae induce motility to enable the bacteria to swim closer to the epithelium. At the epithelium 
where the bile concentrations are reduced V. cholerae instead induce toxin and adhesion genes and repress motil-
ity. The results from pathogenic E. coli instead suggest that bacteria form aggregates as a defense mechanism 
against bile stress. Since the aggregating factors also often mediate attachment to the host epithelium this mech-
anism might allow pathogens to adhere to the epithelium in large constellations and thus develop to a biofilm, 
which might facilitate infection.
Enteropathogenic bacteria hence might use bile as a signaling molecule to modulate virulence. The most 
intriguing result of our study was the substantial increase in the expression and production of CS5 and CexE, 
both of which were upregulated more than 100-fold by NaGCH. Likewise, transcription of the plasmid-encoded 
AraC-like transcriptional regulator csvR was upregulated and this activation was remarkably high during 
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bacterial exponential phase. During stationary phase, bacteria encounters nutrient limitations, accumulation of 
toxic by-products and transcriptional adaptation due to change in σ-factors to cope with stress and starvation60,61. 
These, together with the stress of bile could potentially have disfavored virulence activation. Future investigations 
are needed to determine if these factors are transiently induced using appropriate controls. We showed previously 
that bile induces different strain-specific responses in the transcription and secretion of the heat stable ETEC 
toxin ST and its variants50. Specifically, the STa5-ST variant present in CS6-ETEC strains was induced by bile, 
while estA3/4 encoding the ST variant ST3/4 expressed by in CS5 CS6 ETEC was not50. The present study con-
firmed these results and bile and NaGCH did not up-regulate toxins genes estA3/4 or eltAB encoding LT.
However, the effect of bile on bacterial virulence varies. For instance, bile induced the expression of the afim-
brial LDA adhesion in atypical EPEC39, while bile downregulated stx2 and genes in the locus of enterocyte efface-
ment in E. coli O157:H757. Similarly, V. cholerae exhibits a complex response to bile. In early studies of the V. 
cholerae O1 classical biotype strain O395, bile decreased cholera toxin (CT) production62. When the bacteria 
were exposed to cholate only, CT production was induced directly by ToxR, and CT repression was induced by 
the unsaturated fatty acids in bile63. Exposure to specific bile components such as taurocholate and glycocholate 
also promote virulence in the V. cholerae El Tor biotype18; whereas, deoxycholate and chenodeoxycholate do not. 
This might explain why CS5, cexE, and csvR were upregulated almost two-fold in the presence of pure NaGCH 
compared to crude bile, which consists of a mix of bile salts, unsaturated fatty acids, and other components. These 
studies suggest that bacterial pathogens recognize a specific set of bile salts and interpret them as signals to either 
activate or reduce virulence64.
RNA-Seq of a CS1 + CS3 ETEC reference strain showed that the plasmid-encoded AraC-like transcriptional 
regulator peaR was one of the most differentially expressed genes in the presence of bile salts34. This is in line with 
our finding concerning the araC-like transcription factor csvR and suggests that a general bile response may be 
mediated by the activation of these similar transcription factors. By using PacBio analyses of the E2265 plasmid, 
we found that another AraC-family transcriptional regulator, the ETEC autotransporter encoded by eatA, the 
ST gene (estA3/4), and an aat translocator system were situated downstream of csvR. Interestingly, Santiago, et 
al.65 described a similar genetic organization with similar conserved features, although the precise location and 
genes varied among EAEC, ETEC H10407, (CFA/I) and ETEC 1392/75, (CS1, and CS3), Shiga-toxin producing 
EAEC, and Citrobacter rodentium. Altogether, we suggest that pathogens may harbor a conserved set of genes 
that respond to bile. Our further analysis confirmed that NaGCH induced the Aat translocator operon on the 
ETEC plasmid, while the nearby genes eatA and araC were not induced. The ETEC Aat translocator is homol-
ogous to the Aat (enteroaggregative ABC transporter) complex involved in the translocation of dispersin (Aap, 
anti-aggregation protein) in EAEC, and it is controlled by the major AraC-like transcriptional activator AggR51. 
AggR is similar to CsvR in ETEC. Because AatETEC genes are upstream of cexE, we hypothesize that this transloca-
tor is involved in CexE transport, considering that CexE contains a secretory signal peptide that is removed dur-
ing translocation across the cytoplasmic membrane through the general secretory pathway. However, this should 
be analyzed further. Although the function of cexE is unknown, it is regulated by CfaD/Rns, which regulates the 
CS1 pilus in ETEC strains expressing the colonization factors CFA/I or CS1 + CS3; it is also only present among 
ETEC strains. Consequently, a previous study suggested that it was a virulence gene30 but not further studies on 
its role in virulence were performed. Because cexE expression increased significantly in the presence of bile and 
NaGCH, we suggest a role for cexE during intestinal infections.
In summary, prior to adhesion and infection, bacterial pathogens inevitably come into contact with various 
concentrations of bile salts in the gut lumen; the concentrations are high at the proximal region of the small 
intestine and much lower in the distal region of the small intestine and into the large intestine (Fig. 8). Our data 
indicate that LT STh CS5 + CS6 ETEC interprets the levels of NaGCH in the proximal small intestine as a signal 
to induce gene expression aiming to colonize this specific site.
Materials and Methods
Bacterial strains. The clinical ETEC isolates E1777 and E2265, which both express the CS5 and CS6 col-
onization factors and the LT and STh enterotoxins, were used for transcriptomic and proteomic analyses 
(Supplementary Table S3). The strains were isolated from stool samples from adults with acute diarrheal disease 
at the hospital of the International Centre for Diarrheal Disease Research (icddr,b) in Dhaka, Bangladesh, in April 
2005 and March 2006, respectively17,66. The toxin profile was determined with ELISA and PCR, and the coloniza-
tion factor profile was determined with dot-blot assays for various CFs25. Both strains have been sequenced and 
belong to the global phylogenetic lineage L5 and are multilocus sequence type 44337,66. Clinical isolates from the 
University of Gothenburg ETEC collection were used for additional studies of gene expression and cell adhesion 
(Supplementary Table S3). All strains were kept at −70 °C in glycerol stocks and streaked onto blood agar plates 
to confirm purity before experimentation.
RNA sample preparation. Bacteria were grown from frozen stocks overnight on blood agar plates at 37 °C. 
Starting cultures were prepared by growing 10 colonies in 10 ml of LB medium with shaking to an OD600 of 0.8 
(i.e. 109 bacteria/ml). The cultures were diluted 1:100 into a final volume of either 20 ml LB medium, LB sup-
plemented with 0.15% (w/v) ox-bile extract (Oxoid), or LB supplemented with 0.2% (w/v) sodium glycocholate 
hydrate (NaGCH) (Sigma-Aldrich) and grown in 250 ml Erlenmeyer flasks under aerated conditions at 37 °C 
(200 rpm). The cultures were followed for 5 hours to determine the growth kinetics. Samples were collected for 
RNA extraction after 3 hours of growth, when cultures had reached mid-logarithmic growth and an OD600 of 
2.5 to 3. The samples, containing 1 × 109 bacteria, were immediately mixed with a 2X volume of RNAProtect® 
(Qiagen), incubated at room temperature for 5 minutes, and centrifuged for 10 minutes at 13,000 rpm. Bacterial 
pellets were stored at −70 °C until RNA extraction.
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To prepare total RNA, bacterial cells were lysed with lysozyme (1 mg/ml) and treated with proteinase K using 
the RNeasy Mini Kit (Qiagen), according to the manufacturer’s instructions. RNA purity was confirmed with 
agarose gel electrophoresis, and the concentration was determined with a NanoDrop ND-1000 (NanoDrop 
Technologies). Aliquots of RNA were reserved for cDNA preparation and qRT-PCR. For RNA-Seq, RNA was 
extracted in parallel in duplicate or triplicate from the remaining samples for each culture condition; volumes 
corresponding to 20 µg RNA were pooled and precipitated overnight at −20 °C with a 1:10 volume of 3 M NaAc 
and a 2X volume of 99.5% ethanol. The RNA was centrifuged for 30 minutes at 13,000 rpm, and the pellet was 
washed with 70% ethanol and centrifuged again. The pellets were covered with 200 µl 99.5% ethanol and stored 
at −70 °C until shipment to Shenzhen, China. The RNA integrity, quality, and concentration were validated upon 
arrival to the sequencing facility (Beijing Genome Institute, Shenzhen, China) using an Agilent 2100 Bioanalyzer 
(Agilent Technologies). The RIN values were above 9.8 for all samples.
Quantitative real-time reverse-transcription PCR (qRT-PCR). For each sample, cDNA was prepared 
from 600 ng RNA using the QuantiTect Reverse Transcription Kit (Qiagen). The final volumes of the cDNA 
samples and RT(−) controls were 20 μl, and both were stored at −20 °C until use. QRT-PCR was performed with 
primers specific for csvR, csfD, cssD, cexE, aatP, and gapA (Supplementary Table S3). The program for qRT-PCR 
was run on 20-μl reactions using standard conditions for the LightCycler® 480 Instrument II (Roche Molecular 
Diagnosis), with 30 ng cDNA, 8 pmol of each primer, and 10 μl Power SYBR® Green PCR Master Mix (Applied 
Biosystems). Transcript levels were normalized to the house-keeping gene gapA using the 2−ΔΔCt method; 
qRT-PCR data for each experimental group are expressed as the change in expression relative to bacteria grown 
in LB. For ON experiments, transcript levels were expressed relative to the gene expression of bacteria grown in 
LB at 3 hours. All values reported are the mean of at least three independent experiments.
RNA-Seq. For RNA-Seq, rRNA was depleted with the Illumina Ribo-Zero rRNA Removal Kit for bacteria, 
and Illumina libraries were generated using the TruSeq protocol as described by the manufacturer. The libraries 
were sequenced with the Illumina Hiseq. 2000 system with single-end 100-bp read lengths; approximately 34 
million reads were generated for each sample. Sequences from the raw FASTQ files were first trimmed to obtain 
high-quality reads, using a Phred score cut-off of 30. Reads were then assembled with SOAPdenovo software 
(http://soap.genomics.org.cn/soapdenovo.html). CAP3 was used to assemble the unigenes from different sam-
ples to form a single set of non-redundant unigenes. Unigene sequences with hits in the first or second databases 
were not searched in subsequent databases. Then, BLAST results were used to extract coding regions (CDS) 
from Unigene sequences and translate them into peptide sequences. The BLAST results were then used to train 
ESTScan67. CDS of unigenes with no hits in the BLAST search were predicted with ESTScan and then translated 
into peptide sequences.
Unigenes were functionally annotated for protein sequence similarity and via KEGG pathway, COG, and gene 
ontology (GO) analyses. All unigene sequences were searched in protein databases (Nr Swiss-Prot, KEGG, and 
COG) using BLASTX (e-value < 0.00001). The Blast2GO program was used to obtain GO annotations of the 
unigenes, and WEGO software68 was used to functionally classify all unigenes.
Differential gene expression for the experimental conditions (LB vs. LB + Bile and LB vs. LB + NaGCH) was 
calculated using the fold-change values per gene and per strain (E1777 and E2265) obtained from the RPKM 
values and later log2-transformed. A 3-fold change in gene expression (log2 ≤ −1.58 and log2 ≥ 1.58) was con-
sidered statistically significant.
The R tool gplots::heatmap.2 was used to plot the heatmap of significantly differentially regulated genes. Genes 
were organized by signaling pathway, and each pathway was assigned a color (Fig. 1).
Growth conditions, protein sample preparation, and isobaric labeling for quantitative mass 
spectrometry (iTRAQ-coupled LC-MS/MS). Proteomic analyses were performed on duplicate replicate 
samples; isobaric tags were used for relative and absolute quantitation (iTRAQ) coupled with nano-liquid chro-
matography (LC) and analysis by tandem mass spectrometry (MS/MS).
Starter cultures were prepared by growing 3 colonies in 10 ml LB medium for 3 hours at 37 °C with shak-
ing. Cells from each respective starter culture (E1777 and E2265) were inoculated into two sets of three 250 mL 
flasks containing 25 ml LB medium with or without 0.2% (w/v) NaGCH (Sigma-Aldrich) for a final concentra-
tion of 107 bacteria/ml (based on the OD600 value). The cultures were grown to stationary phase at 37 °C, and 
duplicate cultures were pooled for a total sample volume of 5 to 6 ml. The resulting 8 samples (2 × E1777-LB, 
2 × E1777-NaGCH, 2 × E2265-LB, 2 × E2265-NaGCH) were centrifuged at 10,000 rpm for 5 minutes, and the 
pellets were washed carefully 3 times in PBS and stored at −20 °C.
Proteomic analysis with iTRAQ. Proteomic analyses were performed at the Proteomic Core Facility at 
the Sahlgrenska Academy, Gothenburg University. Bacteria samples were homogenized in 300 µl TEAB (8 M 
urea, 50 mM triethylammonium bicarbonate) using the FastPrep®−24 instrument (MP Biomedicals). An equal 
volume of lysis buffer (50 mM TEAB, 8 M urea, 4% CHAPS, 0.2% SDS, 5 mM EDTA) was added, and the total 
protein concentration was determined with the Pierce™ 660 Protein Assay (Thermo Fisher Scientific). Aliquots 
containing 100 μg protein were reduced and alkylated according to the manufacturer’s instructions (AB Sciex, 
iTRAQ Reagents Multi [4]-Plex Kit). Samples were digested with trypsin (1:25, trypsin:protein; Promega) over-
night in solution at 37 °C. The resulting peptide samples were labeled with the iTRAQ 4-plex reagents and pooled 
into two independent sets. The 2 sets were fractionated into 18 fractions by strong cation exchange chromatog-
raphy (ÄKTA-system, Amersham-Pharmacia) on a PolySULFOETHYL A™ column (100 × 2.1 mm, 5 µm, 300 Å; 
PolyLC Inc.) over 40 minutes (0% to 100% 500 mM ammonium formate, pH 2.8 in 20% ACN).
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Each fraction was desalted using PepClean C18 spin columns (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. Samples were analyzed with an LTQ-Orbitrap Velos mass spectrometer inter-
faced to an Easy-nLC system (Thermo Fisher Scientific). Peptides were separated on a C18 analytical column 
(210 × 0.075 mm ID, 3 μm Reprosil-Pur C18-AQ particles, Dr. Maisch, Germany) over a 70-min gradient from 
5% to 80% ACN in 0.2% formic acid. The MS scans were performed at a resolution of 30,000 with a mass range 
of m/z 400–1800. MS/MS analysis was performed in a data-dependent mode with a resolution of 7,500 and m/z 
120–2,000, with the top 10 most abundant doubly or multiply charged precursor ions in each MS scan selected for 
MS/MS fragmentation. An inclusion list containing eight theoretical tryptic peptides from the protein of interest 
were used during the analysis. Dynamic exclusion was set to 30 seconds.
For relative quantification, the raw MS data files for each iTRAQ set were merged with Proteome Discoverer 
software v. 1.3 (Thermo Fisher Scientific). The database search was performed with the Mascot search engine 
(Matrix Science) and included the Escherichia coli Swiss-Prot Database (updated October 2011; Swiss Institute of 
Bioinformatics, Switzerland) and an in-house database containing the proteins of interest (e.g., variant of cexE in 
E2265). The search used an MS peptide tolerance of 5 ppm and an MS/MS tolerance for identification of 0.5 Da. 
Tryptic peptides were accepted with 1 missed cleavage and variable modifications of methionine oxidation, 
cysteine methylthiol and fixed modifications of N-terminal iTRAQ4plex and lysine iTRAQ4plex were selected. 
The detected-peptide threshold in the software was set to a 1% false-discovery rate by searching against a reversed 
database, and identified proteins that shared sequence were grouped to minimize redundancy. The quantifica-
tion was normalized using the protein median, and missing values were replaced with minimum intensity. Only 
peptides unique for a given protein were considered for relative quantitation, excluding those common to other 
isoforms or proteins of the same family. The results were then exported into Excel for manual data interpretation.
Proteins were considered to be significantly upregulated or downregulated when the fold change between LB 
and LB + NaGCH was ≥1.2 and ≤0.8 with at least two unique peptides.
Deletion of CS5 and CS6 operons. The CS5 and CS6 operon deletion mutants were constructed in strain 
E2265 using the λ-Red recombinase system69. Plasmid pKD4 was used as a template to amplify the kanamycin 
(kan) resistance cassette with primers cs5mutF/cs5mutR or cs6mutF/cs6mutR, incorporating 60 bp of homol-
ogy to the 5′ and 3′ ends of the CS5 or CS6 operons. The purified PCR product was electroporated into E2265 
harboring pKD46. The mutants were selected on LB plates with kanamycin at 37 °C and confirmed by PCR and 
DNA sequencing. Plasmid pKD4 was used as a template to amplify the kanamycin (kan) resistance cassette with 
primers cs5mutF/cs5mutR or cs6mutF/cs6mutR, incorporating 60 bp of homology to the 5′ and 3′ ends of the 
CS5 or CS6 operons. The purified PCR product was electroporated into E2265 harboring pKD46. The mutants 
were selected on LB plates with kanamycin at 37 °C and confirmed by PCR and DNA sequencing.
Cell culture assays. Caco-2 cells (human colon adenocarcinoma cells) were obtained from the American 
Type Culture Collection and used in their terminally differentiated state to mimic mature small intestine entero-
cytes. Caco-2 cells were grown and maintained in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich) 
supplemented with 10% (v/v) fetal bovine serum (FBS) at 37 °C in an atmosphere of 5% CO2/95% air with con-
stant humidity. For the experiments, Caco-2 cells were seeded into 24-well tissue culture plates at 25,000 cells/
cm2 and grown over 15 days to obtain a monolayer of differentiated and polarized cells; the culture medium was 
changed every 3 days. Monolayers were infected with bacteria by replacing the medium with 500 μl of a suspen-
sion of DMEM + 10% FBS with 1 × 107 CFU/ml bacteria (5 × 107 CFU/well) with or without 0.2% NaGCH. After 
3 hours of infection at 37 °C in 5% CO2, the cells were washed 3 times with PBS and lysed with Triton-X 0.1% for 
10 minutes at 37 °C. The lysates were collected, and different dilutions were plated on LB agar and incubated for 
24 hours at 37 °C to determine the CFU. Each experiment was carried out in duplicate and repeated three times.
Crystal violet biofilm assay. Biofilm assays were performed on microtiter plates as described previously70, 
with some modifications. Overnight cultures were inoculated 1:100 into fresh LB medium, LB + 0.15% bile salts, 
or LB + 0.2% NaGCH. 100 μl of each diluted bacterial cultures were grown in a round-bottom 96-well polysty-
rene microtiter plate (Corning® Cat. No. CLS3795 Sigma). Planktonic growth was determined by measuring the 
absorbance (600 nm); wells were then rinsed with water, and attached cells were stained with 125 μl crystal violet 
(Sigma-Aldrich). Stained cells were solubilized with 200 μl 80% ethanol, and 125 μl of the solution was transferred 
to a flat-bottom 96-well polystyrene microtiter plate (Corning®, Cat. No. CLS3595 Sigma). Absorbance (540 nm) 
was measured with a SpectraMax i3x spectrophotometer (Molecular Devices). For each experiment, the absorb-
ance of the blank control with crystal violet was subtracted from each experimental sample. Six replicates were 
used in each experiment, and six independent experiments were performed.
Semi-quantitative detection of extracellular polymeric substances (EPS). EPS matrix detection 
was performed as described previously 72. In brief, 130 l diluted bacterial cultures (1:50 from an overnight bac-
terial) in LB, LB + 0.15% bile or LB + 0.2% NaGCH were grown in a black 96-well clear flat bottom polysty-
rene plate (Corning® Cat. No. CLS3603 Sigma) overnight at 37 °C. Planktonic bacteria was transferred to a new 
96-well polystyrene microtiter plate (Corning®, Cat. No. CLS3595 Sigma). Wells in the black plate were fixated 
with formaldehyde/glutaraldehyde, rinsed with PBS and stained with 150 l of Concanavalin A (ConA) conju-
gated to fluorescein isothiocyanate (FITC) (25 g/ml) for 15 min. After rinsing with PBS, the amount of retained 
ConA-FITC was measured using a SpectraMax i3x spectrophotometer (Molecular Devices) at 480 nm. This assay 
was performed in four independent experiments.
Phenotypic testing for the rdar morphotype. Bacterial strains were grown on LB-no salt agar (LBns) overnight 
at 37 °C and re-suspended in PBS. The bacterial suspension was adjusted to an OD600nm of 3 and 5 μl was spot 
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inoculated onto LBns agar supplemented with Congo red (40 μg/ml) and Coomassie brilliant blue (20μg/ml). The 
plates were additionally supplemented with either 0.15% bile or 0.2% NaGCH. Colony morphology was observed 
after incubation at 37 °C for 48 hours; photographs were taken after incubation.
Motility assay. Swimming media consisted of 1% Tryptone, 0.5% NaCl and 0.25% agar with and without 
0.2% NaGCH were prepared. 10 ml overnight cultures of E1777 and E2265 were concentrated 2-fold by centrif-
ugation, washed and resuspended in PBS. 2 μl of the bacterial cell suspension was inoculated by inserting the tip 
of the pipette at the center of the plate, approximately 2–3 mm inside the swimming agar. Images were obtained 
after 8 hours of incubation at 37 °C. Three independent experiments were performed.
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